Ghent, Belgium

Karel Willy Luc Decroos


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Karel Willy Luc Decroos: Innovator in Pharmaceutical Compositions

Introduction

Karel Willy Luc Decroos is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurodegenerative and neurodevelopmental disorders. With a total of three patents to his name, Decroos continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents is a disclosure on compositions of trofinetide. This patent describes compounds of Formula (I), including stereoisomers and side compounds. It outlines pharmaceutical compositions and methods for manufacturing these compounds using silylation reagents. The focus is on producing compositions and products that utilize these methods, specifically for pharmaceutical applications aimed at treating neurodegenerative or neurodevelopmental disorders.

Career Highlights

Karel Willy Luc Decroos is currently associated with Neuren Pharmaceuticals Limited, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the understanding and treatment of complex neurological conditions.

Collaborations

Decroos has collaborated with notable colleagues such as Clive Blower and James Murray Shaw, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.

Conclusion

Karel Willy Luc Decroos stands out as a significant figure in the realm of pharmaceutical inventions. His work on trofinetide and other compounds showcases his commitment to improving treatments for neurodegenerative disorders. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…